TELA Bio Inc (NAS:TELA)
$ 3.03 0 (0%) Market Cap: 119.35 Mil Enterprise Value: 143.57 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 53/100

Q3 2020 TELA Bio Inc Earnings Call Transcript

Nov 11, 2020 / 09:30PM GMT
Release Date Price: $16.5 (-2.94%)
Operator

Good afternoon, ladies and gentlemen, and welcome to the TELA Bio Third Quarter 2020 Earnings Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.

I would now like to turn the conference over to Stuart Henderson, Vice President, Corporate Development and Investor Relations for TELA Bio.

Stuart M. Henderson
TELA Bio, Inc. - VP of Corporate Development & IR

Thank you, Victor, and good afternoon, everyone. Earlier today, TELA Bio released financial results for the quarter ended September 30, 2020. A copy of the press release is available on the company's website. Joining me on today's call are Tony Koblish, President and CEO; and Nora Brennan, CFO.

Before we begin, I'd like to remind you that during this conference call, the company will make projections and forward-looking statements regarding future events. We encourage you to review the company's past and future filings with the SEC, including, without limitation, the company's Form 10-K filed on March 30, 2020, and 10-Q filed on August 15, 2020,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot